FDA approves DIACOMIT (Stiripentol) for the treatment of seizu...
GENTILLY, France, Aug. 24, 2018 /PRNewswire-AsiaNet/ -- BIOCODEX SAS is pleased to announce that on August 20th, 2018, the Food and Drug Administration (FDA) has approved DIACOMIT (stiripentol) for the treatment of seizures associated with Dravet syndrome (DS) in patients 2 years of age and older takin...
Read more https://view-release/?pr-id=74884